Equities

Shanghai MicroPort EP Medtech Co Ltd

688351:SHH

Shanghai MicroPort EP Medtech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)20.37
  • Today's Change-0.540 / -2.58%
  • Shares traded2.02m
  • 1 Year change-8.20%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Microport EP Medtech Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of medical equipment. The Company is focused on the fields of electrophysiology intervention treatment and ablation treatment, and it is committed to providing integrated diagnosis and ablation treatment solution with precision intervention navigation at its core. The Company’s main products are heart electrophysiology equipment and related supplies. The Company distributes products both in the domestic market and to overseas markets, including France, Italy, and Spain, among others.

  • Revenue in CNY (TTM)383.99m
  • Net income in CNY35.90m
  • Incorporated2010
  • Employees577.00
  • Location
    Shanghai MicroPort EP Medtech Co LtdSHANGHAI 201318ChinaCHN
  • Phone+86 2 160969600
  • Fax+86 2 120903925
  • Websitehttps://www.everpace.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HOB Biotech Group Corp Ltd401.29m35.26m7.44bn550.00219.119.50--19.330.56140.56146.3512.950.41021.378.23729,609.803.609.944.3312.1061.8765.308.7919.530.943839.420.119232.5923.1014.3813.643.3446.19--
Shanghai Microport EP MedTech Co Ltd383.99m35.90m9.84bn577.00267.045.54--24.960.07630.07630.8163.680.20811.307.04665,493.301.95--2.05--57.86--9.35--13.82--0.0109--26.46--85.17------
Vcanbio Cell & Gene Engineering Corp Ltd1.59bn107.45m10.16bn2.21k88.832.71--6.140.23540.23543.457.730.29771.902.59721,260.301.901.132.681.6168.1067.766.383.841.487.890.02960.002.243.78-5.7812.43-7.11--
Shenzhen YHLO Biotech Co Ltd1.90bn288.64m10.58bn1.76k36.373.92--5.480.50260.50263.324.660.48421.074.581,081,307.005.8516.437.4624.1663.9853.2612.0820.011.289.130.247430.28-48.4223.02-64.9356.3228.88--
Shinva Medical Instrument Co Ltd10.12bn692.34m10.92bn8.21k12.761.46--1.081.411.4118.3112.340.67752.204.961,232,589.004.724.639.1410.7625.6224.226.966.120.8303--0.163715.917.87-0.534230.7895.70-5.9061.86
Qingdao Haier Biomedical Co Ltd2.24bn358.01m11.35bn2.64k30.782.56--4.931.131.137.0413.530.40185.126.38848,473.706.5611.498.2915.2247.8249.9816.3425.202.53--0.031626.53-20.3622.07-32.4128.9420.64--
Shandong Weigao Orthopaedic Devce Co Ltd1.28bn154.60m11.78bn2.21k73.872.91--8.880.38580.38583.209.780.25240.67144.03581,131.603.1410.973.9513.6962.4077.3312.4327.083.62--0.009617.90-30.551.17-79.36-19.11-4.31--
Beijing Wandong Medical Technolgy Co Ltd1.40bn184.09m12.02bn1.06k67.522.62--8.860.2620.2622.006.740.26472.764.011,325,746.003.505.303.916.2138.8345.2113.2216.469.48--0.017935.8210.305.327.514.22-16.665.39
Data as of Nov 15 2024. Currency figures normalised to Shanghai MicroPort EP Medtech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

38.53%Per cent of shares held by top holders
HolderShares% Held
China Universal Asset Management Co., Ltd.as of 30 Jun 202418.51m14.99%
China Fund Management Co., Ltd.as of 30 Jun 20246.78m5.49%
Bank of China Investment Management Co., Ltd.as of 30 Jun 20245.08m4.11%
New China Fund Management Co., Ltd.as of 30 Jun 20243.97m3.22%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20243.19m2.58%
Ping An Asset Management Co., Ltd.as of 30 Sep 20232.26m1.83%
Tian Hong Asset Management Co., Ltd.as of 30 Sep 20232.04m1.65%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20241.97m1.60%
ABC-CA Fund Management Co., Ltd.as of 30 Jun 20241.90m1.54%
China Asset Management Co., Ltd.as of 30 Jun 20241.90m1.53%
More ▼
Data from 30 Jun 2024 - 04 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.